Cancer Seminar Series

The Cancer Seminar Series is a joint University and Saolta education initiative by - and for - clinical, academic and research staff, students, and trainees. 

Presenters are invited from the fields of cancer science, survivorship, clinical care, education and innovation, with the aim of encouraging interdisciplinary activities and communication. 

Seminars will take place on the first working Monday of the month in the Clinical Science Institute CSI 1031 (Small Lecture Theatre) and online for colleagues across Saolta University hospitals and Medical Academies.

The series is hosted by Dr Michael McCarthy, Consultant Medical Oncologist. CPD credits are applicable for HSE staff. It is not a public seminar series and the seminars are not recorded. 

Zoom Link: 

06/11/23 Dr Natalie Hession, Cancer Services Principal Psycho-Oncologist, GUH Psycho-Oncology: A Vision for the West
04/12/23 Medical Physics, GUH Physics Input in the Patient Oncology Pathway
08/01/24 Ms Ger Walpole, RANP Haematology, SUH Empowering Care: ANP-led Oral Anti Cancer Medication Clinics leading the way in expansion of cancer care
12/02/24  Dr Michael McCarthy, Consultant Medical Oncologist, GUH  Medical Oncology Service: Updates 2024
04/03/24 Ms Rachel Macken and Ms Martina Kinnane
Senior Medical Social Workers, GUH
Oncology Social Work: A Systemic Focus - Ar scáth a chéile a mhaireann na daoine
15/04/24 Ms Patricia Gleeson, AYA Cancer Clinical Nurse Specialist "A Lost Tribe" - AYA Cancer Overview and Patient Case Study

Postgraduate Cancer Education

Undergraduate Cancer Research

Medical students can apply to undertake 6-8 weeks of research as part of an annual summer research programme. The call for applications is issued by the School of Medicine Research Committee. 

An annual School of Medicine Undergraduate Research Day takes place in October in the Clinical Science Institute.

There are also opportunities for undergraduate students in the School of Biological and Chemical Sciences to do their final year projects with cancer research groups.